Request for Covid-19 Impact Assessment of this Report
The United States Alpha Galactosidase A market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Alpha Galactosidase A market, reaching US$ million by the year 2028. As for the Europe Alpha Galactosidase A landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Alpha Galactosidase A players cover Amicus Therapeutics, Inc., Greenovation Biotech GmbH, iBio, Inc., and ISU ABXIS Co.,Ltd., etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Alpha Galactosidase A market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Agalsidase Alfa
AVRRD-01
Migalastat Hydrochloride
MOSS-AGAL
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospital
Clinic
Home Care
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Amicus Therapeutics, Inc.
Greenovation Biotech GmbH
iBio, Inc.
ISU ABXIS Co.,Ltd.
JCR Pharmaceuticals Co., Ltd.
Pharming Group N.V.
Protalix BioTherapeutics, Inc.
Takeda
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Alpha Galactosidase A Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Alpha Galactosidase A by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Alpha Galactosidase A by Country/Region, 2017, 2022 & 2028
2.2 Alpha Galactosidase A Segment by Type
2.2.1 Agalsidase Alfa
2.2.2 AVRRD-01
2.2.3 Migalastat Hydrochloride
2.2.4 MOSS-AGAL
2.2.5 Others
2.3 Alpha Galactosidase A Sales by Type
2.3.1 Global Alpha Galactosidase A Sales Market Share by Type (2017-2022)
2.3.2 Global Alpha Galactosidase A Revenue and Market Share by Type (2017-2022)
2.3.3 Global Alpha Galactosidase A Sale Price by Type (2017-2022)
2.4 Alpha Galactosidase A Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Home Care
2.5 Alpha Galactosidase A Sales by Application
2.5.1 Global Alpha Galactosidase A Sale Market Share by Application (2017-2022)
2.5.2 Global Alpha Galactosidase A Revenue and Market Share by Application (2017-2022)
2.5.3 Global Alpha Galactosidase A Sale Price by Application (2017-2022)
3 Global Alpha Galactosidase A by Company
3.1 Global Alpha Galactosidase A Breakdown Data by Company
3.1.1 Global Alpha Galactosidase A Annual Sales by Company (2020-2022)
3.1.2 Global Alpha Galactosidase A Sales Market Share by Company (2020-2022)
3.2 Global Alpha Galactosidase A Annual Revenue by Company (2020-2022)
3.2.1 Global Alpha Galactosidase A Revenue by Company (2020-2022)
3.2.2 Global Alpha Galactosidase A Revenue Market Share by Company (2020-2022)
3.3 Global Alpha Galactosidase A Sale Price by Company
3.4 Key Manufacturers Alpha Galactosidase A Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Alpha Galactosidase A Product Location Distribution
3.4.2 Players Alpha Galactosidase A Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Alpha Galactosidase A by Geographic Region
4.1 World Historic Alpha Galactosidase A Market Size by Geographic Region (2017-2022)
4.1.1 Global Alpha Galactosidase A Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Alpha Galactosidase A Annual Revenue by Geographic Region
4.2 World Historic Alpha Galactosidase A Market Size by Country/Region (2017-2022)
4.2.1 Global Alpha Galactosidase A Annual Sales by Country/Region (2017-2022)
4.2.2 Global Alpha Galactosidase A Annual Revenue by Country/Region
4.3 Americas Alpha Galactosidase A Sales Growth
4.4 APAC Alpha Galactosidase A Sales Growth
4.5 Europe Alpha Galactosidase A Sales Growth
4.6 Middle East & Africa Alpha Galactosidase A Sales Growth
5 Americas
5.1 Americas Alpha Galactosidase A Sales by Country
5.1.1 Americas Alpha Galactosidase A Sales by Country (2017-2022)
5.1.2 Americas Alpha Galactosidase A Revenue by Country (2017-2022)
5.2 Americas Alpha Galactosidase A Sales by Type
5.3 Americas Alpha Galactosidase A Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Alpha Galactosidase A Sales by Region
6.1.1 APAC Alpha Galactosidase A Sales by Region (2017-2022)
6.1.2 APAC Alpha Galactosidase A Revenue by Region (2017-2022)
6.2 APAC Alpha Galactosidase A Sales by Type
6.3 APAC Alpha Galactosidase A Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Alpha Galactosidase A by Country
7.1.1 Europe Alpha Galactosidase A Sales by Country (2017-2022)
7.1.2 Europe Alpha Galactosidase A Revenue by Country (2017-2022)
7.2 Europe Alpha Galactosidase A Sales by Type
7.3 Europe Alpha Galactosidase A Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Alpha Galactosidase A by Country
8.1.1 Middle East & Africa Alpha Galactosidase A Sales by Country (2017-2022)
8.1.2 Middle East & Africa Alpha Galactosidase A Revenue by Country (2017-2022)
8.2 Middle East & Africa Alpha Galactosidase A Sales by Type
8.3 Middle East & Africa Alpha Galactosidase A Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Alpha Galactosidase A
10.3 Manufacturing Process Analysis of Alpha Galactosidase A
10.4 Industry Chain Structure of Alpha Galactosidase A
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Alpha Galactosidase A Distributors
11.3 Alpha Galactosidase A Customer
12 World Forecast Review for Alpha Galactosidase A by Geographic Region
12.1 Global Alpha Galactosidase A Market Size Forecast by Region
12.1.1 Global Alpha Galactosidase A Forecast by Region (2023-2028)
12.1.2 Global Alpha Galactosidase A Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Alpha Galactosidase A Forecast by Type
12.7 Global Alpha Galactosidase A Forecast by Application
13 Key Players Analysis
13.1 Amicus Therapeutics, Inc.
13.1.1 Amicus Therapeutics, Inc. Company Information
13.1.2 Amicus Therapeutics, Inc. Alpha Galactosidase A Product Offered
13.1.3 Amicus Therapeutics, Inc. Alpha Galactosidase A Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Amicus Therapeutics, Inc. Main Business Overview
13.1.5 Amicus Therapeutics, Inc. Latest Developments
13.2 Greenovation Biotech GmbH
13.2.1 Greenovation Biotech GmbH Company Information
13.2.2 Greenovation Biotech GmbH Alpha Galactosidase A Product Offered
13.2.3 Greenovation Biotech GmbH Alpha Galactosidase A Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Greenovation Biotech GmbH Main Business Overview
13.2.5 Greenovation Biotech GmbH Latest Developments
13.3 iBio, Inc.
13.3.1 iBio, Inc. Company Information
13.3.2 iBio, Inc. Alpha Galactosidase A Product Offered
13.3.3 iBio, Inc. Alpha Galactosidase A Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 iBio, Inc. Main Business Overview
13.3.5 iBio, Inc. Latest Developments
13.4 ISU ABXIS Co.,Ltd.
13.4.1 ISU ABXIS Co.,Ltd. Company Information
13.4.2 ISU ABXIS Co.,Ltd. Alpha Galactosidase A Product Offered
13.4.3 ISU ABXIS Co.,Ltd. Alpha Galactosidase A Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 ISU ABXIS Co.,Ltd. Main Business Overview
13.4.5 ISU ABXIS Co.,Ltd. Latest Developments
13.5 JCR Pharmaceuticals Co., Ltd.
13.5.1 JCR Pharmaceuticals Co., Ltd. Company Information
13.5.2 JCR Pharmaceuticals Co., Ltd. Alpha Galactosidase A Product Offered
13.5.3 JCR Pharmaceuticals Co., Ltd. Alpha Galactosidase A Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 JCR Pharmaceuticals Co., Ltd. Main Business Overview
13.5.5 JCR Pharmaceuticals Co., Ltd. Latest Developments
13.6 Pharming Group N.V.
13.6.1 Pharming Group N.V. Company Information
13.6.2 Pharming Group N.V. Alpha Galactosidase A Product Offered
13.6.3 Pharming Group N.V. Alpha Galactosidase A Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Pharming Group N.V. Main Business Overview
13.6.5 Pharming Group N.V. Latest Developments
13.7 Protalix BioTherapeutics, Inc.
13.7.1 Protalix BioTherapeutics, Inc. Company Information
13.7.2 Protalix BioTherapeutics, Inc. Alpha Galactosidase A Product Offered
13.7.3 Protalix BioTherapeutics, Inc. Alpha Galactosidase A Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Protalix BioTherapeutics, Inc. Main Business Overview
13.7.5 Protalix BioTherapeutics, Inc. Latest Developments
13.8 Takeda
13.8.1 Takeda Company Information
13.8.2 Takeda Alpha Galactosidase A Product Offered
13.8.3 Takeda Alpha Galactosidase A Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Takeda Main Business Overview
13.8.5 Takeda Latest Developments
14 Research Findings and Conclusion
Table 1. Alpha Galactosidase A Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Alpha Galactosidase A Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Agalsidase Alfa
Table 4. Major Players of AVRRD-01
Table 5. Major Players of Migalastat Hydrochloride
Table 6. Major Players of MOSS-AGAL
Table 7. Major Players of Others
Table 8. Global Alpha Galactosidase A Sales by Type (2017-2022) & (K Pcs)
Table 9. Global Alpha Galactosidase A Sales Market Share by Type (2017-2022)
Table 10. Global Alpha Galactosidase A Revenue by Type (2017-2022) & ($ million)
Table 11. Global Alpha Galactosidase A Revenue Market Share by Type (2017-2022)
Table 12. Global Alpha Galactosidase A Sale Price by Type (2017-2022) & (USD/Pcs)
Table 13. Global Alpha Galactosidase A Sales by Application (2017-2022) & (K Pcs)
Table 14. Global Alpha Galactosidase A Sales Market Share by Application (2017-2022)
Table 15. Global Alpha Galactosidase A Revenue by Application (2017-2022)
Table 16. Global Alpha Galactosidase A Revenue Market Share by Application (2017-2022)
Table 17. Global Alpha Galactosidase A Sale Price by Application (2017-2022) & (USD/Pcs)
Table 18. Global Alpha Galactosidase A Sales by Company (2020-2022) & (K Pcs)
Table 19. Global Alpha Galactosidase A Sales Market Share by Company (2020-2022)
Table 20. Global Alpha Galactosidase A Revenue by Company (2020-2022) ($ Millions)
Table 21. Global Alpha Galactosidase A Revenue Market Share by Company (2020-2022)
Table 22. Global Alpha Galactosidase A Sale Price by Company (2020-2022) & (USD/Pcs)
Table 23. Key Manufacturers Alpha Galactosidase A Producing Area Distribution and Sales Area
Table 24. Players Alpha Galactosidase A Products Offered
Table 25. Alpha Galactosidase A Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Alpha Galactosidase A Sales by Geographic Region (2017-2022) & (K Pcs)
Table 29. Global Alpha Galactosidase A Sales Market Share Geographic Region (2017-2022)
Table 30. Global Alpha Galactosidase A Revenue by Geographic Region (2017-2022) & ($ millions)
Table 31. Global Alpha Galactosidase A Revenue Market Share by Geographic Region (2017-2022)
Table 32. Global Alpha Galactosidase A Sales by Country/Region (2017-2022) & (K Pcs)
Table 33. Global Alpha Galactosidase A Sales Market Share by Country/Region (2017-2022)
Table 34. Global Alpha Galactosidase A Revenue by Country/Region (2017-2022) & ($ millions)
Table 35. Global Alpha Galactosidase A Revenue Market Share by Country/Region (2017-2022)
Table 36. Americas Alpha Galactosidase A Sales by Country (2017-2022) & (K Pcs)
Table 37. Americas Alpha Galactosidase A Sales Market Share by Country (2017-2022)
Table 38. Americas Alpha Galactosidase A Revenue by Country (2017-2022) & ($ Millions)
Table 39. Americas Alpha Galactosidase A Revenue Market Share by Country (2017-2022)
Table 40. Americas Alpha Galactosidase A Sales by Type (2017-2022) & (K Pcs)
Table 41. Americas Alpha Galactosidase A Sales Market Share by Type (2017-2022)
Table 42. Americas Alpha Galactosidase A Sales by Application (2017-2022) & (K Pcs)
Table 43. Americas Alpha Galactosidase A Sales Market Share by Application (2017-2022)
Table 44. APAC Alpha Galactosidase A Sales by Region (2017-2022) & (K Pcs)
Table 45. APAC Alpha Galactosidase A Sales Market Share by Region (2017-2022)
Table 46. APAC Alpha Galactosidase A Revenue by Region (2017-2022) & ($ Millions)
Table 47. APAC Alpha Galactosidase A Revenue Market Share by Region (2017-2022)
Table 48. APAC Alpha Galactosidase A Sales by Type (2017-2022) & (K Pcs)
Table 49. APAC Alpha Galactosidase A Sales Market Share by Type (2017-2022)
Table 50. APAC Alpha Galactosidase A Sales by Application (2017-2022) & (K Pcs)
Table 51. APAC Alpha Galactosidase A Sales Market Share by Application (2017-2022)
Table 52. Europe Alpha Galactosidase A Sales by Country (2017-2022) & (K Pcs)
Table 53. Europe Alpha Galactosidase A Sales Market Share by Country (2017-2022)
Table 54. Europe Alpha Galactosidase A Revenue by Country (2017-2022) & ($ Millions)
Table 55. Europe Alpha Galactosidase A Revenue Market Share by Country (2017-2022)
Table 56. Europe Alpha Galactosidase A Sales by Type (2017-2022) & (K Pcs)
Table 57. Europe Alpha Galactosidase A Sales Market Share by Type (2017-2022)
Table 58. Europe Alpha Galactosidase A Sales by Application (2017-2022) & (K Pcs)
Table 59. Europe Alpha Galactosidase A Sales Market Share by Application (2017-2022)
Table 60. Middle East & Africa Alpha Galactosidase A Sales by Country (2017-2022) & (K Pcs)
Table 61. Middle East & Africa Alpha Galactosidase A Sales Market Share by Country (2017-2022)
Table 62. Middle East & Africa Alpha Galactosidase A Revenue by Country (2017-2022) & ($ Millions)
Table 63. Middle East & Africa Alpha Galactosidase A Revenue Market Share by Country (2017-2022)
Table 64. Middle East & Africa Alpha Galactosidase A Sales by Type (2017-2022) & (K Pcs)
Table 65. Middle East & Africa Alpha Galactosidase A Sales Market Share by Type (2017-2022)
Table 66. Middle East & Africa Alpha Galactosidase A Sales by Application (2017-2022) & (K Pcs)
Table 67. Middle East & Africa Alpha Galactosidase A Sales Market Share by Application (2017-2022)
Table 68. Key Market Drivers & Growth Opportunities of Alpha Galactosidase A
Table 69. Key Market Challenges & Risks of Alpha Galactosidase A
Table 70. Key Industry Trends of Alpha Galactosidase A
Table 71. Alpha Galactosidase A Raw Material
Table 72. Key Suppliers of Raw Materials
Table 73. Alpha Galactosidase A Distributors List
Table 74. Alpha Galactosidase A Customer List
Table 75. Global Alpha Galactosidase A Sales Forecast by Region (2023-2028) & (K Pcs)
Table 76. Global Alpha Galactosidase A Sales Market Forecast by Region
Table 77. Global Alpha Galactosidase A Revenue Forecast by Region (2023-2028) & ($ millions)
Table 78. Global Alpha Galactosidase A Revenue Market Share Forecast by Region (2023-2028)
Table 79. Americas Alpha Galactosidase A Sales Forecast by Country (2023-2028) & (K Pcs)
Table 80. Americas Alpha Galactosidase A Revenue Forecast by Country (2023-2028) & ($ millions)
Table 81. APAC Alpha Galactosidase A Sales Forecast by Region (2023-2028) & (K Pcs)
Table 82. APAC Alpha Galactosidase A Revenue Forecast by Region (2023-2028) & ($ millions)
Table 83. Europe Alpha Galactosidase A Sales Forecast by Country (2023-2028) & (K Pcs)
Table 84. Europe Alpha Galactosidase A Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Middle East & Africa Alpha Galactosidase A Sales Forecast by Country (2023-2028) & (K Pcs)
Table 86. Middle East & Africa Alpha Galactosidase A Revenue Forecast by Country (2023-2028) & ($ millions)
Table 87. Global Alpha Galactosidase A Sales Forecast by Type (2023-2028) & (K Pcs)
Table 88. Global Alpha Galactosidase A Sales Market Share Forecast by Type (2023-2028)
Table 89. Global Alpha Galactosidase A Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 90. Global Alpha Galactosidase A Revenue Market Share Forecast by Type (2023-2028)
Table 91. Global Alpha Galactosidase A Sales Forecast by Application (2023-2028) & (K Pcs)
Table 92. Global Alpha Galactosidase A Sales Market Share Forecast by Application (2023-2028)
Table 93. Global Alpha Galactosidase A Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 94. Global Alpha Galactosidase A Revenue Market Share Forecast by Application (2023-2028)
Table 95. Amicus Therapeutics, Inc. Basic Information, Alpha Galactosidase A Manufacturing Base, Sales Area and Its Competitors
Table 96. Amicus Therapeutics, Inc. Alpha Galactosidase A Product Offered
Table 97. Amicus Therapeutics, Inc. Alpha Galactosidase A Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 98. Amicus Therapeutics, Inc. Main Business
Table 99. Amicus Therapeutics, Inc. Latest Developments
Table 100. Greenovation Biotech GmbH Basic Information, Alpha Galactosidase A Manufacturing Base, Sales Area and Its Competitors
Table 101. Greenovation Biotech GmbH Alpha Galactosidase A Product Offered
Table 102. Greenovation Biotech GmbH Alpha Galactosidase A Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 103. Greenovation Biotech GmbH Main Business
Table 104. Greenovation Biotech GmbH Latest Developments
Table 105. iBio, Inc. Basic Information, Alpha Galactosidase A Manufacturing Base, Sales Area and Its Competitors
Table 106. iBio, Inc. Alpha Galactosidase A Product Offered
Table 107. iBio, Inc. Alpha Galactosidase A Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 108. iBio, Inc. Main Business
Table 109. iBio, Inc. Latest Developments
Table 110. ISU ABXIS Co.,Ltd. Basic Information, Alpha Galactosidase A Manufacturing Base, Sales Area and Its Competitors
Table 111. ISU ABXIS Co.,Ltd. Alpha Galactosidase A Product Offered
Table 112. ISU ABXIS Co.,Ltd. Alpha Galactosidase A Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 113. ISU ABXIS Co.,Ltd. Main Business
Table 114. ISU ABXIS Co.,Ltd. Latest Developments
Table 115. JCR Pharmaceuticals Co., Ltd. Basic Information, Alpha Galactosidase A Manufacturing Base, Sales Area and Its Competitors
Table 116. JCR Pharmaceuticals Co., Ltd. Alpha Galactosidase A Product Offered
Table 117. JCR Pharmaceuticals Co., Ltd. Alpha Galactosidase A Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 118. JCR Pharmaceuticals Co., Ltd. Main Business
Table 119. JCR Pharmaceuticals Co., Ltd. Latest Developments
Table 120. Pharming Group N.V. Basic Information, Alpha Galactosidase A Manufacturing Base, Sales Area and Its Competitors
Table 121. Pharming Group N.V. Alpha Galactosidase A Product Offered
Table 122. Pharming Group N.V. Alpha Galactosidase A Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 123. Pharming Group N.V. Main Business
Table 124. Pharming Group N.V. Latest Developments
Table 125. Protalix BioTherapeutics, Inc. Basic Information, Alpha Galactosidase A Manufacturing Base, Sales Area and Its Competitors
Table 126. Protalix BioTherapeutics, Inc. Alpha Galactosidase A Product Offered
Table 127. Protalix BioTherapeutics, Inc. Alpha Galactosidase A Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 128. Protalix BioTherapeutics, Inc. Main Business
Table 129. Protalix BioTherapeutics, Inc. Latest Developments
Table 130. Takeda Basic Information, Alpha Galactosidase A Manufacturing Base, Sales Area and Its Competitors
Table 131. Takeda Alpha Galactosidase A Product Offered
Table 132. Takeda Alpha Galactosidase A Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 133. Takeda Main Business
Table 134. Takeda Latest Developments
List of Figures
Figure 1. Picture of Alpha Galactosidase A
Figure 2. Alpha Galactosidase A Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Alpha Galactosidase A Sales Growth Rate 2017-2028 (K Pcs)
Figure 7. Global Alpha Galactosidase A Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Alpha Galactosidase A Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Agalsidase Alfa
Figure 10. Product Picture of AVRRD-01
Figure 11. Product Picture of Migalastat Hydrochloride
Figure 12. Product Picture of MOSS-AGAL
Figure 13. Product Picture of Others
Figure 14. Global Alpha Galactosidase A Sales Market Share by Type in 2021
Figure 15. Global Alpha Galactosidase A Revenue Market Share by Type (2017-2022)
Figure 16. Alpha Galactosidase A Consumed in Hospital
Figure 17. Global Alpha Galactosidase A Market: Hospital (2017-2022) & (K Pcs)
Figure 18. Alpha Galactosidase A Consumed in Clinic
Figure 19. Global Alpha Galactosidase A Market: Clinic (2017-2022) & (K Pcs)
Figure 20. Alpha Galactosidase A Consumed in Home Care
Figure 21. Global Alpha Galactosidase A Market: Home Care (2017-2022) & (K Pcs)
Figure 22. Global Alpha Galactosidase A Sales Market Share by Application (2017-2022)
Figure 23. Global Alpha Galactosidase A Revenue Market Share by Application in 2021
Figure 24. Alpha Galactosidase A Revenue Market by Company in 2021 ($ Million)
Figure 25. Global Alpha Galactosidase A Revenue Market Share by Company in 2021
Figure 26. Global Alpha Galactosidase A Sales Market Share by Geographic Region (2017-2022)
Figure 27. Global Alpha Galactosidase A Revenue Market Share by Geographic Region in 2021
Figure 28. Global Alpha Galactosidase A Sales Market Share by Region (2017-2022)
Figure 29. Global Alpha Galactosidase A Revenue Market Share by Country/Region in 2021
Figure 30. Americas Alpha Galactosidase A Sales 2017-2022 (K Pcs)
Figure 31. Americas Alpha Galactosidase A Revenue 2017-2022 ($ Millions)
Figure 32. APAC Alpha Galactosidase A Sales 2017-2022 (K Pcs)
Figure 33. APAC Alpha Galactosidase A Revenue 2017-2022 ($ Millions)
Figure 34. Europe Alpha Galactosidase A Sales 2017-2022 (K Pcs)
Figure 35. Europe Alpha Galactosidase A Revenue 2017-2022 ($ Millions)
Figure 36. Middle East & Africa Alpha Galactosidase A Sales 2017-2022 (K Pcs)
Figure 37. Middle East & Africa Alpha Galactosidase A Revenue 2017-2022 ($ Millions)
Figure 38. Americas Alpha Galactosidase A Sales Market Share by Country in 2021
Figure 39. Americas Alpha Galactosidase A Revenue Market Share by Country in 2021
Figure 40. United States Alpha Galactosidase A Revenue Growth 2017-2022 ($ Millions)
Figure 41. Canada Alpha Galactosidase A Revenue Growth 2017-2022 ($ Millions)
Figure 42. Mexico Alpha Galactosidase A Revenue Growth 2017-2022 ($ Millions)
Figure 43. Brazil Alpha Galactosidase A Revenue Growth 2017-2022 ($ Millions)
Figure 44. APAC Alpha Galactosidase A Sales Market Share by Region in 2021
Figure 45. APAC Alpha Galactosidase A Revenue Market Share by Regions in 2021
Figure 46. China Alpha Galactosidase A Revenue Growth 2017-2022 ($ Millions)
Figure 47. Japan Alpha Galactosidase A Revenue Growth 2017-2022 ($ Millions)
Figure 48. South Korea Alpha Galactosidase A Revenue Growth 2017-2022 ($ Millions)
Figure 49. Southeast Asia Alpha Galactosidase A Revenue Growth 2017-2022 ($ Millions)
Figure 50. India Alpha Galactosidase A Revenue Growth 2017-2022 ($ Millions)
Figure 51. Australia Alpha Galactosidase A Revenue Growth 2017-2022 ($ Millions)
Figure 52. Europe Alpha Galactosidase A Sales Market Share by Country in 2021
Figure 53. Europe Alpha Galactosidase A Revenue Market Share by Country in 2021
Figure 54. Germany Alpha Galactosidase A Revenue Growth 2017-2022 ($ Millions)
Figure 55. France Alpha Galactosidase A Revenue Growth 2017-2022 ($ Millions)
Figure 56. UK Alpha Galactosidase A Revenue Growth 2017-2022 ($ Millions)
Figure 57. Italy Alpha Galactosidase A Revenue Growth 2017-2022 ($ Millions)
Figure 58. Russia Alpha Galactosidase A Revenue Growth 2017-2022 ($ Millions)
Figure 59. Middle East & Africa Alpha Galactosidase A Sales Market Share by Country in 2021
Figure 60. Middle East & Africa Alpha Galactosidase A Revenue Market Share by Country in 2021
Figure 61. Egypt Alpha Galactosidase A Revenue Growth 2017-2022 ($ Millions)
Figure 62. South Africa Alpha Galactosidase A Revenue Growth 2017-2022 ($ Millions)
Figure 63. Israel Alpha Galactosidase A Revenue Growth 2017-2022 ($ Millions)
Figure 64. Turkey Alpha Galactosidase A Revenue Growth 2017-2022 ($ Millions)
Figure 65. GCC Country Alpha Galactosidase A Revenue Growth 2017-2022 ($ Millions)
Figure 66. Manufacturing Cost Structure Analysis of Alpha Galactosidase A in 2021
Figure 67. Manufacturing Process Analysis of Alpha Galactosidase A
Figure 68. Industry Chain Structure of Alpha Galactosidase A
Figure 69. Channels of Distribution
Figure 70. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...